Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
Development of an indirect competitive enzyme-linked immunosorbent assay (icELISA) using highly specific monoclonal antibody against paclitaxel
6-dimethyl-2-oxo-3-pyridinyl)methyl]-3-[[trans-4-(dimethylamino)cyclohexyl]ethylamino]-2-methylbenzamide
3-dimethylbutanamido]-4-methylpentanamido]pentanoyl]-N-ethylpyrrolidine-2-carboxamide
CAS Number: 105816-04-4
5% is minimally irritating
ATR inhibitor 2 oxamide Tromethamine Development of an indirect competitiveATR inhibitor 2 is an ATP competitive, orally active, and selective ATR inhibitor, with a Ki of <150 pM. ATR inhibitor 2 potently inhibits ATR driven phosphorylated checkpoint kinase 1 (Chk1) phosphorylation with an IC50 of 8 nM. Antitumor activity. Product information CAS Number: 1613191 99 3 Molecular Weight: 541. 55 Formula: C25H29F2N9O3 Chemical Name: 2 amino 6 fluoro N (5 fluoro 4 {4 [4 (oxetan 3 yl)piperazine 1 carbonyl]piperidin 1 yl}pyridin 3